Johnson & Johnson Services, Inc., Medtronic And B. Braun Melsungen are Dominating the Market for Global Hernia Mesh Repair Devices Market In 2016

Global Hernia Mesh Repair Devices Market is expected to reach USD 5,952.26 million by 2024 from USD 4,170.27 million in 2016, at a CAGR of 4.7%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Access Full Report:- https://www.databridgemarketresearch.com/reports/global-hernia-mesh-repair-devices-market#

The global hernia mesh repair devices market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. The global hernia mesh repair devices market is dominated Johnson & Johnson Services, Inc., followed by Medtronic and B. Braun Melsungen. Other players in this market include C R BARD, INC, W.L GORE & ASSOCIATES, INC, ATRIUM, ACELITY L.P. INC, among others holds 31.6% of the global hernia mesh repair devices market in 2016.

JOHNSON & JOHNSON SERVICES INC:

Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Johnson & Johnson Services, Inc.is involved in multinational medical devices, pharmaceutical and consumer packaged goods manufacturing.  The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices. The pharmaceutical segment offers a wide range of products for five major therapeutic applications—immunology, infectious diseases, neuroscience, oncology, and cardiovascular & metabolic diseases. The consumer segment of the company offers various products pertaining to baby care, oral care, skin care, women’s health, and wound care. The medical devices segment of the company offers various devices to be used in therapeutic areas such as orthopedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care.

Johnson & Johnson has more than 265 operating companies across the United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. Ethicon US, LLC., subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. Some of its subsidiaries include Janssen Pharmaceuticals (Belgium), Ethicon Inc. (U.S.), DePuy (U.S.), Neutrogena (U.S.), Synthes (Switzerland), Cordis Corporation (U.S.), LifeScan, Inc. (U.S.), Janssen-Cilag (U.S.), McNeil Consumer Healthcare (U.S.), Janssen Biotech, Inc. (U.S.), Ortho Clinical Diagnostics (U.S.), and Mentor Worldwide LLC (U.S.)..

Medtronic:

Founded in 1949 and headquartered in Minneapolis, U.S.. Medtronic is the world’s largest standalone medical technology development and a global healthcare solution company. The company operates in cardiac and vascular group (cardiac rhythm and heart failure, coronary and structural heart, aortic and peripheral vascular), minimally invasive therapies group (surgical solutions and patient monitoring & recovery), restorative therapies (spine, brain therapies, speciality therapies and pain therapies), and diabetes group (intensive insulin management, non- intensive diabetes therapies, Diabetes service and solutions).

The company operates in more than 155 countries worldwide with more than 260 locations in research and development, manufacturing and distribution, and education centers. The company’s regional locations are Asia Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, North America, and Western Europe. Some of its subsidiaries include Medtronic Belgium S.A./N.V. (Belgium), Dantec Elettronica S.r.l. (Rome), Medtronic (Shanghai) Ltd. (China), Medtronic B.V. (Netherlands), Medtronic Xomed Limited (U.K) and many more

Braun Melsungen AG:

1. Braun Melsungen AG was founded in 1839 and it is headquartered at Melsungen in Germany. It is one of the world’s leading manufacturers and providers of healthcare solutions. The company operates through sixteen business segments- cardiac-thoracic surgery, diabetes care, infection prevention, laproscopic surgery, orthopaedic joint replacement, wound management, continence care and urology, extracorporeal blood treatment, infusion therapy, neuro surgery, pain therapy, degenerative spinal disorders, general open surgery, interventional vascular diagnostics and therapy, nutrition therapy, and ostomy care The general open surgery segment offers a wide range of products such as surgical instruments, wound closure staplers, seal and cut, ligature clips, electro surgery and power systems.
2. Braun product range comprises of 5000 different product out of which 95 percent are manufactured by the company. The company has offices and facilities in more than 50 countries. B. Braun and its subsidiaries currently employ more than 54000 people in more than 60 countries. Some of its subsidiaries are B. Braun Melsungen Inc. (U.S),B. Braun Medical Pvt. Ltd. (India),B. Braun Surgical GmbH (Germany), B. BraunAvitum AG (Colombia) among others. Together with its subsidiaries it manufactures, markets, and sells various healthcare products and services for intensive care units, anesthesia and emergency care, extracorporeal blood treatment, and surgical core procedures all over the world.